Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung
This study has been completed.
Sponsor:
Tel-Aviv Sourasky Medical Center
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00511290
First received: August 2, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In the present study inflammatory mediators will be isolated in induced sputum and exhaled breath condensate and will be correlated with particulate matter measured in these samples.Particulate matter will be assessed by partcle size distribution method and shape analysis.
The aim of the study is to perform biological monitoring in environmental and occupational diseases in a non invassive fashion.
| Condition | Intervention |
|---|---|
|
Asthma Chronic Obstructive Pulmonary Disease Interstitial Lung Diseases Occupational Lung Diseases |
Other: no generic names |
| Study Type: | Observational |
| Study Design: | Allocation: Random Sample Primary Purpose: Screening Time Perspective: Longitudinal Time Perspective: Retrospective |
Resource links provided by NLM:
MedlinePlus related topics:
Asthma
COPD (Chronic Obstructive Pulmonary Disease)
Interstitial Lung Diseases
Occupational Health
Pulmonary Fibrosis
U.S. FDA Resources
Further study details as provided by Tel-Aviv Sourasky Medical Center:
Eligibility| Ages Eligible for Study: | 7 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Ages 7-80
Exclusion Criteria:
- FEV1 < 75% predicted pO2 < 75
Contacts and Locations More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00511290 History of Changes |
| Other Study ID Numbers: | TASMC-07-LF-07316-CTIL |
| Study First Received: | August 2, 2007 |
| Last Updated: | August 2, 2007 |
| Health Authority: | Israel: Ethics Commission |
Keywords provided by Tel-Aviv Sourasky Medical Center:
|
Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases |
Additional relevant MeSH terms:
|
Asthma Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive Pulmonary Fibrosis Lung Diseases, Interstitial Lung Diseases, Obstructive |
Bronchial Diseases Respiratory Tract Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on May 22, 2013